Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI : Added Value of Diffusion Weighted Imaging
|ClinicalTrials.gov Identifier: NCT01780766|
Recruitment Status : Unknown
Verified January 2013 by Steven Pans, Universitaire Ziekenhuizen Leuven.
Recruitment status was: Recruiting
First Posted : January 31, 2013
Last Update Posted : January 31, 2013
Whole body MRI with diffusion weighted imaging is a useful imaging tool
- staging and diagnosis
- therapy monitoring All patients will be scanned before and during treatment. The findings on diffusion weighted imaging will be correlated to the golden standard (computer tomography and MRI (T1 and STIR)).
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI: What is the Added Value of Diffusion Weighted Imaging in Diagnosis and Follow-up|
|Study Start Date :||September 2008|
|Estimated Primary Completion Date :||March 2013|
|Estimated Study Completion Date :||September 2014|
|Indolent myeloma patient|
|Symptomatic Myeloma patient|
- Validation [ Time Frame: 2 years ]Validation of whole body MRI diffusion-weighted imaging in multiple myeloma at 3 Tesla MRI: correlation of the new MRI imaging technique (diffusion weighted imaging)to standard validated imaging technique (Computer Tomography and Magnetic Resonance Imaging)
- Therapy assessment [ Time Frame: 4 years ]
Whole body MRI with Diffusion weighted imaging is useful for treatment monitoring in multiple myeloma patients during and after therapy.
Measurement of apparent diffusion coefficient (ADC) and comparison of ADC before, during and after therapy. Correlation of ADC with clinical findings and standard MRI findings.
- outcome [ Time Frame: 5 years ]correlation between early treatment response and outcome of the patient by measuring apparent diffusion coefficient
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01780766
|Contact: Steven Pans, MDemail@example.com|
|University Hospitals Leuven||Recruiting|
|Contact: Steven Pans, MD 3216340505 firstname.lastname@example.org|
|Principal Investigator:||Steven Pans, MD||Universitaire Ziekenhuizen Leuven|